{"transactions":[{"id":811717,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53119,"kind":"person","name":"Cote Elissa S.","position":1,"cik":"0002069951","reported_name":"Cote Elissa S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp Development Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-04-10T00:38:30.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":75000,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0002069951-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2069951/000206995126000004/edgardoc.xml","form_type":"4"}},{"id":1101868,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53119,"kind":"person","name":"Cote Elissa S.","position":1,"cik":"0002069951","reported_name":"Cote Elissa S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:16:37.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were granted in connection with the Reporting Person's appointment as Chief Corporate Development Officer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest on June 23, 2026 (the \"Vesting Start Date\") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.96,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-25-018206","document":"form4-06252025_090633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2069951/000141588925018206/form4-06252025_090633.xml","form_type":"4"}}]}